凯赛生物：2025年净利润5.66亿元，同比增长15.70%

Core Viewpoint - The company reported a revenue of 3.295 billion yuan for the fiscal year 2025, reflecting a year-on-year increase of 11.41% [1] - The total profit reached 632 million yuan, marking a year-on-year growth of 15.23% [1] - The net profit attributable to shareholders was 566 million yuan, with a year-on-year rise of 15.70% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 526 million yuan, showing a year-on-year increase of 13.17% [1] Financial Performance - Revenue for 2025: 3.295 billion yuan, up 11.41% year-on-year [1] - Total profit: 632 million yuan, up 15.23% year-on-year [1] - Net profit attributable to shareholders: 566 million yuan, up 15.70% year-on-year [1] - Net profit after deducting non-recurring items: 526 million yuan, up 13.17% year-on-year [1]